Condition
Infective Keratitis
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
Early P 1 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06967376Early Phase 1CompletedPrimary
The Role of Adjuvant Corneal Crosslinking in the Management of Infective Keratitis
NCT04969640CompletedPrimary
Role of Anterior Segment Optical Coherence Tomography in Infectious Keratitis
NCT05387993CompletedPrimary
Microbial Keratitis in Cairo University Hospitals
NCT04894630Not ApplicableCompletedPrimary
Infective Keratitis in Minia Governate
Showing all 4 trials